The hidden side of clinical trials

Watch the AllTrials TEDx talk on YouTube

Learn more

Evidence matters to the public

Join us on 1st November at Parliament to make the case

Learn more

Plant Science Panel

Insecticides, biofuels, GMOs …

Learn more

'The Ugly Truth'

by Tracey Brown, director of Sense About Science

Learn more

For the record

Interpretation of clinical trial data

In April 2007, the The Daily Telegraph ran a story linking non-steroidal anti-inflammatory drug use with an increased risk of heart attack. The article was headlined “High doses of ibuprofen raises heart attack risk” and stated that that for some individuals the risk of heart attack or stroke is nine times higher when taking ibuprofen. According to this report, these results will bring more anxiety to the millions of arthritis sufferers in Britain (published 6th April 2007).

You can read The Daily Telegraph article here

Here, Dr Shaun Treweek, specialist in the methodology of randomised controlled trials, responds:

The original research should not bring more anxiety to the millions of arthritis sufferers in Britain as the “nine times greater risk” is not based on thousands of patients but nine. Eight of 373 patients (2.14%) taking ibuprofen and aspirin had an adverse outcome compared to one of 394 patients (0.25%) taking an alternative drug and aspirin. The authors of the research themselves say that the risk could be as low as 1.13 or as high as 72.76. This huge range is exactly what you’d expect with so few patients and makes the estimate of risk largely meaningless. The study’s authors do point out that their research has many limitations and say it should be used for future research ideas rather than as a statement on the risks of ibuprofen.

Author: Sense About Science

Document type: For The Record

Published: 24 May 2007

Back · New For The Record search